Roche Diagnostics Revenues Rise 7 Percent in 2018
Post# of 11802
(Total Views: 240)
Posted On: 01/31/2019 1:21:28 PM
Roche Diagnostics Revenues Rise 7 Percent in 2018
https://www.genomeweb.com/molecular-diagnosti...FM74svsa0M
Diabetes Care sales grew 1 percent (2 percent at constant exchange rates) in 2018 to CHF 1.98 billion, from CHF 1.97 billion in 2017, contributing 16 percent to diagnostics sales. Blood glucose monitoring grew 2 percent, while insulin delivery systems sales decreased 6 percent. Growth in this segment was mainly driven by the Accu-Chek Guide and the Accu-Chek instant blood glucose monitoring systems. Roche said it received "encouraging customer feedback" for its new Accu-Chek Solo micropump, which it has launched in pilot markets. Heuer said the diabetes care segment has reached "a certain level of stabilization" after not performing well in the past.
https://www.genomeweb.com/molecular-diagnosti...FM74svsa0M
Diabetes Care sales grew 1 percent (2 percent at constant exchange rates) in 2018 to CHF 1.98 billion, from CHF 1.97 billion in 2017, contributing 16 percent to diagnostics sales. Blood glucose monitoring grew 2 percent, while insulin delivery systems sales decreased 6 percent. Growth in this segment was mainly driven by the Accu-Chek Guide and the Accu-Chek instant blood glucose monitoring systems. Roche said it received "encouraging customer feedback" for its new Accu-Chek Solo micropump, which it has launched in pilot markets. Heuer said the diabetes care segment has reached "a certain level of stabilization" after not performing well in the past.
(0)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼